ECORelectroCore, Inc.

electroCore (NASDAQ:ECOR) reported second-quarter 2026 revenue of $9.5 million, up approximately 28% from $7.4 million a year earlier, as growth in Veterans Affairs prescription sales and direct-to-consumer Truvaga sales lifted results. The company raised its full-year revenue outlook to growth of m

electroCore (ECOR) delivered earnings and revenue surprises of +19.51% and +0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Rigel (RIGL) delivered earnings and revenue surprises of -3.30% and +14.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

electroCore (NASDAQ:ECOR) Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial insurance channels and consumer wellness markets. Speaking at the LD Micro event,

Thomas Errico: Good afternoon, everyone, and thank you for joining electroCore, Inc.'s first quarter 2026 earnings call. This is the first earnings call since we announced our leadership transition, and I want to take a moment to share how encouraged I am by the progress we have made executing that transition and by the momentum we continue to see across the organization. At the same time, Michael Fox joined us as chief operating officer on April 13, bringing more than 35 years of commercial leadership experience across complex healthcare markets, including extensive work within the federal systems and the U.S. Department of Veteran Affairs.

Moby summary of electroCore, Inc.'s Q1 2026 earnings call

electroCore (NASDAQ:ECOR) executives highlighted record quarterly revenue, expanding margins, and continued progress toward profitability during the company’s first-quarter 2026 earnings call, while also discussing a leadership transition and commercial priorities across federal and consumer channel

electroCore (ECOR) delivered earnings and revenue surprises of -0.86% and +7.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Executives at Ecora Resources (LON:ECOR) told investors that 2025 marked a “landmark year” for the royalty company, highlighted by a shift toward critical minerals, the acquisition of a producing copper stream, and rapid deleveraging despite the added debt used to fund growth. Critical minerals bec

The latest work on Ecora Royalties edges the modelled fair value from £1.71 to £1.72, a small move that still matters if you are tracking where analysts think the shares could reasonably trade over time. This sits alongside a wider mix of views, with some analysts lifting targets while others sit closer to 154 GBp and have shifted from Buy to Hold, highlighting a more divided stance on risk and execution. Read on to see how to interpret these shifting targets and keep up with the evolving...